RAD001 enhances the potency of BEZ235 to inhibit mTOR signaling and tumor growth.

RAD001 enhances the potency of BEZ235 to inhibit mTOR signaling and tumor growth.

The mammalian target of rapamycin (mTOR) is regulated by oncogenic growth factor signals and plays a pivotal role in controlling cellular metabolism, growth and survival. Everolimus (RAD001) is an allosteric mTOR inhibitor that has shown marked efficacy in certain cancers but is unable to completely...

Full description

Bibliographic Details
Main Authors: Beat Nyfeler, Yan Chen, Xiaoyan Li, Maria Pinzon-Ortiz, Zuncai Wang, Anupama Reddy, Elina Pradhan, Rita Das, Joseph Lehár, Robert Schlegel, Peter M Finan, Z Alexander Cao, Leon O Murphy, Alan Huang
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3498278?pdf=render

Internet

http://europepmc.org/articles/PMC3498278?pdf=render

Similar Items